 |
| Dr Zhibin (Ben) Chen |
An international study led by Monash University scientists has shown that tolerability to antiseizure medication (ASM) has not improved over 30 years. This was despite the advent of nearly 20 ‘second-generation’ drugs – those developed after 1980 – designed to better the earlier treatments.
Tolerability is a key determinant of the effectiveness of epilepsy treatment; greater effort to improve it was needed in ASM development, the paper urges.
